{"altmetric_id":16296580,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["AnnemarieVtW"],"posts_count":1}},"citation":{"altmetric_jid":"52d6c0eb3cf058b0448b4567","authors":["R Langfelder","S Cattaneo","L Migliavada","P Delsole"],"doi":"10.1136\/ejhpharm-2016-000875.138","first_seen_on":"2017-02-10T12:56:09+00:00","issns":["2047-9956","2047-9964"],"issue":"Suppl 1","journal":"European Journal of Hospital Pharmacy","last_mentioned_on":1486731268,"links":["http:\/\/ejhp.bmj.com\/content\/23\/Suppl_1\/A60.3"],"pdf_url":"http:\/\/ejhp.bmj.com\/content\/ejhpharm\/23\/Suppl_1\/A60.3.full.pdf","pubdate":"2016-03-01T00:00:00+00:00","publisher":"British Medical Journal Publishing Group","startpage":"A60","title":"CP-138 The biosimilar infliximab in rheumatoid arthritis: Use and potential savings in ASL Milano","type":"article","uri":"http:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2016-000875.138","volume":"23","mendeley_url":"http:\/\/www.mendeley.com\/research\/cp138the-biosimilar-infliximab-rheumatoid-arthritis-potential-savings-asl-milano"},"altmetric_score":{"score":0.25,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":8187659,"mean":6.9230329122133,"rank":7085748,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":8187659,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":266702,"mean":12.886059422349,"rank":221440,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":266702,"percentile":1},"this_journal":{"total_number_of_other_articles":358,"mean":4.8785322128852,"rank":327,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":358,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":42,"mean":8.2170731707317,"rank":37,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":42,"percentile":1}}},"demographics":{"poster_types":{"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Student  > Master":1},"by_discipline":{"Social Sciences":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"NL":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/AnnemarieVtW\/statuses\/830037216181231616","license":"gnip","citation_ids":[16296580],"posted_on":"2017-02-10T12:54:28+00:00","author":{"name":"A. Vroom - Ten Wolde","url":"http:\/\/nl.linkedin.com\/in\/annemarievroomtenwolde","image":"https:\/\/pbs.twimg.com\/profile_images\/1118347634\/Annemarie-photo_normal.png","description":"PhD Organic Chemistry; Science Writer #Biotech\/#Pharma #biologics #biosimilars #biosimilar #mAbs #ADCs #bispecifics #biobetters #bionexpresso","id_on_source":"AnnemarieVtW","tweeter_id":"185567498","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":2208},"tweet_id":"830037216181231616"}]}}